Immunic investor relations
Witryna31 gru 2024 · Results of Operations. The Company reported a net loss of $41.5 million for the year ended December 31, 2024, which compared with a net loss of $52.1 million for the prior year. This resulted in a net loss of $0.98 per share for the year ended December 31, 2024, as compared to a net loss of $1.31 per share for 2024, on both a … Witryna26 lut 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information. Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group …
Immunic investor relations
Did you know?
http://www.neurobopharma.com/ Witryna8 mar 2024 · Archived Events. Date. Event Details. Mar 8, 2024 10:30 AM EST. 43rd Annual Cowen Health Care Conference. Listen to webcast. Feb 6, 2024 4:30 PM EST. Arrowhead Pharmaceuticals 2024 First Quarter Results. Listen to webcast.
Witryna10 paź 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. Rx Communications Group Paula Schwartz +1 917 633 7790 [email protected]. US Media ... Witryna10 lis 2024 · Members of Immunic's management and investor relations teams will attend this virtual conference. To schedule a meeting, please contact an Evercore representative. ... Head of Investor Relations ...
Witryna5 kwi 2024 · Immunic is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune … Investor Relations. IR Home; News Releases; Events and Presentations; Stock … Webcasts and presentations that have been archived are available by viewing hi… 1200 Avenue of the Americas Suite 200 New York, NY 10036, USA Phone: +1 3… Immunic Therapeutics Jessica Breu Head of Investor Relations and Communic… Immunic is privately held and supported by several renowned healthcare invest… Witryna29 kwi 2016 · About Immunic. Immunic AG (www.immunic.de) is a start-up biotech company founded in April 2016 and focused on the development of immune modulators to block Th17- and Th1-mediated immune and autoimmune responses. The company’s two development programs include orally available, small molecule inhibitors of …
Witryna3 lis 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information. …
Witryna3 lis 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] duty drawback refund procedure in indiaWitryna3 lis 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx … duty drawback specialist trainingWitryna14 kwi 2024 · Immunic Inc. (NASDAQ: IMUX)’s stock price has soared by 10.14 in relation to previous closing price of 1.38. Nevertheless, the company has seen a loss of -1.94% in its stock price over the last five trading days. According a new report published by BloombergNEF on investment in the energy ... duty drawback trainingWitrynaManager Investor Relations and Communications Immunic AG. 2 Jahre und 6 Monate, Mai 2016 - Okt. 2024. Junior Consultant Public and Investor Relations MC Services AG. 1 Jahr und 2 Monate, März … in addition acronymWitryna23 lut 2024 · /PRNewswire/ -- Immunic, Inc. (NASDAQ: ... Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … in addition a synonymWitryna24 lut 2024 · /PRNewswire/ -- Immunic, Inc. (Nasdaq: ... Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx Communications Group Paula Schwartz in addition also another signal wordsWitrynaSEC Filings. Select the filing type and date range you wish to view from the drop-down menus below. An annual report to security holders. Open An annual report to security holders. in HTML. Open An annual report to security holders. in DOC file. Open An annual report to security holders. in PDF file. in addition anderes wort